 PALO ALTO, Calif., May 20, 2021 PRNewswire -- Kodiak Sciences Inc. Nasdaq: KOD, a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, today announced that management will present at the following upcoming virtual investor conferences: Jefferies Virtual Healthcare Conference on Thursday, June 3 at 1:00 p.m. 